Aevi Genomic Medicine competitorsClear all

Aevi Genomic Medicine's top competitors include MicrofluidX, Affinia Therapeutics, Nouscom and Orchard Therapeutics.
Aevi Genomic Medicine
Aevi Genomic Medicine
Aevi Genomic Medicine is dedicated to translating genetic discoveries into novel therapies.
MicrofluidX
MicrofluidX
MicrofluidX is a company that develops cell bioprocessing technology.
Affinia Therapeutics
Affinia Therapeutics
Affinia Therapeutics is a biotech company.
Nouscom
Nouscom
Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
Orchard Therapeutics
Orchard Therapeutics
Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell gene therapy to restore normal gene function in primary immune deficiencies, metabolic diseases, and hematological disorders.
Founding Date
Founding Date
2000
Founding Date
2018
Founding Date
2019
Founding Date
2015
Founding Date
2015
Type
Type
Public
Type
Private
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Wayne, US HQ
Locations
HQ
Locations
HQ
Locations
Basel, CH HQ
Roma, IT
Locations
London, GB HQ
Boston, US
Boston, US
Foster City, US
Menlo Park, US
Employees
Employees
24
Employees
5
Employees
303% increase
Employees
24
Employees
252
Valuation ($)
Valuation ($)
8.2 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
418.6 m
Twitter followers
Twitter followers
N/A
Twitter followers
38
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
784
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
12
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
4.3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Alexa Website Rank
260380
Alexa Website Rank
N/A
Alexa Website Rank
186102
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
1
Employee Rating
4.2

Financial

Net income
Net income
($41.9m) (FY, 2016)
Net income
N/A
Net income
N/A
Net income
N/A
Net income
(£184.4m) (FY, 2018)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 1.7m (6 months ago)
Latest funding round
$ 60m (7 months ago)
Latest funding round
$ 49m (almost 3 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
N/A
Total funding raised
$ 1.7m
Total funding raised
$ 60m
Total funding raised
$ 62.6m
Total funding raised
$ 310.7m
For sources of this data, please see the company profile

View company profiles

MicrofluidX
HQ
Employees
5

MicrofluidX is a company that develops cell bioprocessing technology.

View company
Affinia Therapeutics
HQ
Employees
30↑ 3% increase

Affinia Therapeutics is a biotech company.

View company
Nouscom
HQ
Basel, CH
Employees
24

Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.

View company
Orchard Therapeutics
HQ
London, GB
Employees
252

Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell gene therapy to restore normal gene function in primary immune deficiencies, metabolic diseases, and hematological disorders.

View company